| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003385 Diagnosing nervous system disorders via presence of mutation/polymorphism in parkin gene |
| 01/06/2005 | US20050003384 Surface expression libraries of heteromeric receptors |
| 01/06/2005 | US20050003383 Linoleate isomerase |
| 01/06/2005 | US20050003380 Selective gene amplification |
| 01/06/2005 | US20050003379 Real happy mapping |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003368 Cancer monitoring and therapeutics |
| 01/06/2005 | US20050003367 Methods and compositions for rapid development of screening assays |
| 01/06/2005 | US20050003363 Method of screening for agents inhibiting chloride intracellular channels |
| 01/06/2005 | US20050003361 Method and kit for proximity probing with multivalent proximity probes |
| 01/06/2005 | US20050003357 Novel promoters inducible by dna damaging conditions or agents and uses thereof |
| 01/06/2005 | US20050003354 Generating enhanced regulatory region via random rearrangement of transcriptional activating components; immproving efficiency ofheterologous gene expression |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003349 High titer recombinant influenza viruses for vaccines and gene therapy |
| 01/06/2005 | US20050003344 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations |
| 01/06/2005 | US20050002998 Method for improving stability and shelf-life of liposome complexes |
| 01/06/2005 | US20050002965 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002933 Proliferation and/or differentiation of stem and progenitor cells from embryo or adult |
| 01/06/2005 | US20050002932 Alleviation of symptoms associated with inflammatory disease states |
| 01/06/2005 | US20050002928 Treatment with anti-ErbB2 antibodies |
| 01/06/2005 | US20050002924 Pharmaceutical composition containing sFcgammaR IIb or sFcgammaR III |
| 01/06/2005 | US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine |
| 01/06/2005 | US20050002908 Method for producing a recombinant adeno-associated virus, suitable means therefor and use for producing a medicament |
| 01/06/2005 | US20050002907 Mutated woodchuck posttranscriptional regulatory element (WPRE) sequence having ablated X protein tumorigenic activity; safely used in retroviral and lentiviral vectors to enhance expression levels of heterologous genes or nucleotides |
| 01/06/2005 | US20050002906 Preferentially amplifying in tumors following cancer cell activation of specific gene regulatory region |
| 01/06/2005 | US20050002905 RAAV vector-based pro-opiomelanocortin compositions and methods of use |
| 01/06/2005 | US20050002903 Gene delivery system and methods of use |
| 01/06/2005 | US20050001050 Liquid dispense head and manufacturing method thereof |
| 01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | CA2771875A1 Variant humicola grisea cbh1.1 |
| 01/06/2005 | CA2538349A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 01/06/2005 | CA2530566A1 Methods of making plants that exhibit enhanced disease resistance |
| 01/06/2005 | CA2530388A1 Modified binding molecules comprising connecting peptides |
| 01/06/2005 | CA2530248A1 Modified vectors for organelle transfection |
| 01/06/2005 | CA2530184A1 Method of selecting patients suitable for wt1 vaccine |
| 01/06/2005 | CA2530125A1 Use of double-stranded ribonucleic acid for inducing cell lysis |
| 01/06/2005 | CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof |
| 01/06/2005 | CA2529945A1 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | CA2529103A1 Use of a recombinant vector encoding il-10 for treating neuropathic pain |
| 01/06/2005 | CA2528591A1 Glp-1 analog fusion proteins |
| 01/06/2005 | CA2528544A1 Compositions and methods for regulating polysaccharides of a plant cell |
| 01/06/2005 | CA2528536A1 Transcription factors |
| 01/06/2005 | CA2528511A1 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | CA2528281A1 Methods for identifying agents, which regulate cytokines |
| 01/06/2005 | CA2527959A1 Plant fatty acid amide hydrolases |
| 01/06/2005 | CA2527958A1 Methods and compositions for enhancing the efficacy and specificity of rnai |
| 01/06/2005 | CA2527648A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
| 01/06/2005 | CA2527636A1 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | CA2527022A1 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 01/06/2005 | CA2526639A1 Chimeric rnas and their use for cancer diagonostics and therapy |
| 01/06/2005 | CA2526343A1 Ancestral viruses and vaccines |
| 01/06/2005 | CA2526080A1 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 01/06/2005 | CA2525956A1 Plant breeding method |
| 01/06/2005 | CA2525333A1 Trichoderma genes |
| 01/06/2005 | CA2525251A1 Cd20-specific antibodies and methods of employing same |
| 01/06/2005 | CA2522867A1 Genes encoding carotenoid compounds |
| 01/05/2005 | EP1494031A2 Novel human genes and gene expression products |
| 01/05/2005 | EP1493826A1 Container for carrying out and monitoring biological processes |
| 01/05/2005 | EP1493825A2 Method for producing nucleic acid ligands |
| 01/05/2005 | EP1493818A2 Nucleoside triphosphates and their incorporation into ribozymes |
| 01/05/2005 | EP1493817A1 Resistance against plant pests |
| 01/05/2005 | EP1493816A1 Methods and means for regulating gene expression |
| 01/05/2005 | EP1493815A1 Novel fusion protein recovery and purification methods |
| 01/05/2005 | EP1493814A1 Cell-free synthesis of polyketides |
| 01/05/2005 | EP1493813A1 Flagellar genetic sequences of Brucella being of therapeutic and diagnostic use |
| 01/05/2005 | EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity |
| 01/05/2005 | EP1493811A1 Novel promoters |
| 01/05/2005 | EP1493810A1 DNA-based aptamers for human cathepsin G |
| 01/05/2005 | EP1493809A1 Recombinant dna having hydantoinase gene and carbamylase gene and process for producing amino acid |
| 01/05/2005 | EP1493808A1 Vectors based on novel plasmids derived from Lactobacillus plantarum |
| 01/05/2005 | EP1493749A1 Novel HCV core + 1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
| 01/05/2005 | EP1493446A1 Modified truncated complement system regulators |
| 01/05/2005 | EP1493445A1 Inhibition of stress-induced ligand-dependent EGFR activation |
| 01/05/2005 | EP1493035A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell |
| 01/05/2005 | EP1493033A2 Sc6 for diagnosis of hypoxia related conditions |
| 01/05/2005 | EP1493032A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1493027A2 Methods, systems, and software for identifying functional bio-molecules |
| 01/05/2005 | EP1492891A1 Methods of virus production |
| 01/05/2005 | EP1492887A1 Methods and devices for performing chemical reactions on a solid support |
| 01/05/2005 | EP1492885A2 Schizophrenia associated genes |
| 01/05/2005 | EP1492884A2 Methods of diagnosing and treating colorectal cancer |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492882A1 Methods and reagents for assaying protein kinase activity |
| 01/05/2005 | EP1492877A2 Improved method for the production of vitamin b12 |
| 01/05/2005 | EP1492876A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 01/05/2005 | EP1492875A1 Adeno-associated virus producer system |
| 01/05/2005 | EP1492874A1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
| 01/05/2005 | EP1492873A2 Lipase genes and proteins |
| 01/05/2005 | EP1492872A1 Expression of phospholipid:diacylglycerine acyltransferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids |
| 01/05/2005 | EP1492871A2 Cancer associated protein kinases and their uses |